Shares in crypto exchange Gemini dropped below their IPO price of $28 after plunging another 12% in the last 24 hours.

MapLight Therapeutics is a clinical-stage biopharma focused on CNS disorders and has filed for a $100M U.S. IPO to fund its ...

Indonesia needs coordinated systematic reform to transform its capital markets from a collection of well-intentioned programs ...

Rivian (NASDAQ: RIVN) has grown immensely since the company went public in 2021. At the time of its IPO, sales were essentially zero. Today, annual revenues are above $5 billion. That's an incredible ...

Prosus N.V. is rated Buy. PROSF stock saw strong Tencent growth, NAV discount, and profitable e-commerce drives value. See ...

This year’s biggest spenders per On3 are, in order, Texas, Texas Tech, Ohio State, Oregon, Texas A&M/Miami (tied), ...

The loyalty that Thinky’s employees have to Murati has also attracted investors. When she left OpenAI, where Murati had a ...

The ASX has shed half a percentage point in trade today, shoved lower by losses in tech despite gold prices reaching a fresh all-time high.

Inside the online show that's become a must-watch for tech bros everywhere.

Tim Beyers: We duel, you decide. Two Fools make the case for and against DocuSign. You're listening to Motley Fool Money. Hello, I'm Tim Beyers, lead advisor of Motley Fool Rule Breakers, and here ...

China says Nvidia broke antimonopoly laws, health plan subsidies in play, bank merger market heats up, and more news to start your day.

Paramount Skydance eyes Warner Bros Discovery, and there's a new richest person in the world as Oracle tries to take on big ...